Tocotrienol for liver protection in alcoholic fatty liver disease
Part of Digestive system clinical trials.
This study tests whether a natural form of vitamin E (called tocotrienol) can protect the liver in people with alcoholic fatty liver disease who have stopped drinking. It aims to see if this supplement improves liver health and reduces inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old.
- You need a history of drinking problems and signs of liver inflammation from alcohol (like abnormal liver tests).
- Your liver disease must be mild enough that you do not need steroids or other strong treatments.
- You must be willing to completely stop drinking alcohol for the study period.
- You cannot have other liver conditions (like hepatitis B or C, non-alcoholic fatty liver disease, or autoimmune liver disease), and you must not be obese or have metabolic syndrome.
- You should not be taking certain medications (like steroids, diabetes drugs, blood thinners, or high-dose pain relievers) or vitamin E or herbal supplements in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tocotrienol, a form of vitamin E from palm oil, can help reduce aging-related cell damage in people aged 35–64. Researchers will check if this supplement is safe and effective for generally healthy adults.
This study tests whether a herbal supplement can improve liver function in people with alcoholic liver disease. If you have liver damage from alcohol but not severe cirrhosis, this supplement may help your liver recover.
This study tests whether giving a protein called alpha-1 antitrypsin can help people with severe liver inflammation caused by heavy drinking. It may reduce the damage and improve recovery.
This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
This trial tests whether a special nutritional supplement can protect the liver in people with chronic hepatitis C. If you have mild to moderate liver damage and meet the criteria, you may be able to join.
Hear when a new Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.